American Oriental Bioengineering to Report Fourth Quarter and Full Year 2007 Financi...( NEW YORK Feb. 27 /- American Orie...),Health
Navigation Links
American Oriental Bioengineering to Report Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008
NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products, today announced that it plans to release fourth quarter and full year 2007 financial results on the morning of Thursday, March 6, 2008 before the market opens.
The Company will hold a conference call that morning at 8:00 am ET to discuss results. Listeners may access the call by dialing 1-866-454-4207 or 1-913-981-5575 for international callers. A webcast will also be available through the Company's website at http://www.bioaobo.com. A replay of the call will be available through March 13, 2008. Listeners may access the replay by dialing 1-888-203-1112 or 1-719-457-0820 for international callers, access code: 4824427.
ABOUT AMERICAN ORIENTAL BIOENGINEERING INC.:
American Oriental Bioengineering, Inc. is a leading, fully integrated, plant-based pharmaceutical and plant-based nutraceutical company dedicated to improving health through the development, manufacture and commercialization of modernized plant-based products in China.
Statements made in this press release are forward-looking and are made
pursuant to the safe harbor provisions of the Securities Litigation Reform
Act of 1995. Such statements involve risks and uncertainties that may cause
actual results to differ materially from those set forth in these
statements. The economic, competitive, governmental, technological and
other factors identified in the Company's filings with the Securities and
Exchange Commission, including the Form 10-K for the year ended December
31, 2006, may cause actual results or events to di
'/>"/>
| SOURCE American Oriental Bioengineering, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. African Americans Show Facial Aging in Eyes Earlier Than Caucasians
2. Video: YMCAs Commit to Helping Americans Keep Their New Years Resolutions in Support of Health and Well-Being
3. Vital Health Technologies, Inc. / Caribbean American Health Resorts Inc. Acquires Momentum Medical Group, Inc.
4. More Elderly Americans Living With Heart Failure
5. Sound the Alert!!! - March 25 is the 20th Annual American Diabetes Alert(R) Day
6. AXA Equitable Helps Americans Prepare for a Long Retirement
7. American Laser Centers Names Bill Van Huis as Chief Revenue Officer
8. American Chemical Societys Weekly PressPac -- Feb. 20, 2008
9. American Heart Month Double Dares Women to Beat Health Foes
10. Check Your Emergency Preparedness Kits When You Set Your Clocks, Says New American Public Health Association Campaign
11. Reynolds American Subsidiary to Receive Payment Following Gallaher Joint-Venture Termination
Post Your Comments:
(Date:12/3/2009)... , Leading mental health researchers are warning ...s of climate change will be on mental health, yet ...at the UN climate change conference in Copenhagen ...rom the Institute of Psychiatry (IoP) at King,s Co...y scientists into the potential mental health impa...
(Date:12/3/2009)... 20-year study shows it cut risk factors linked t..., THURSDAY, Dec. 3 (HealthDay News) -- Breast-fe...ficantly lower a woman,s risk of metabolic syndrom...tors -- years later, reports a new study appearing...women who didn,t have pregnancy-related (gestation...
(Date:12/3/2009)... , Cindi Kessock receives... Tulsa, OK (PRWEB) December 2, 2009 -- C...m offering HRMS and ERP applications to businesses...Annual Employee Awards., , ,Each year at their com...evement among their employees. This year, Cindi K...
(Date:12/3/2009)... , Insightra Medical, Inc...announced the launch of its new ventral hernia rep...he standard sublay technique, which completely obv...turing. , (PRWEB) Decembe...based medical device company today announced the l...
(Date:12/3/2009)... , , McALLEN, Texas, Dec. 3 /PRNewswire...SG ), announced today that it has acquired three T...Terrace Rehabilitation & Healthcare Center in ...p; Healthcare in Brownsville; and the 95-bed Veran...he acquisitions were effective December 1, 2009. ,...
Breaking Medicine News(10 mins):Health News:Major impacts of climate change expected on mental health 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 3Health News:CS3 Technology Announces Annual Employee Awards 2Health News:CS3 Technology Announces Annual Employee Awards 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 2Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 4Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 2Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 3[0] Major impacts of climate change expected on mental health[0] Breast-Feeding Can Help Mom's Heart Decades Later[0] CS3 Technology Announces Annual Employee Awards[0] Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing[0] The Ensign Group Acquires Three Texas Skilled Nursing Facilities
...RIE, La., April 15 OrthoSynetics(TM), the largest...dental practices,worldwide, has expanded its sales...ve experience in the orthodontic industry., "Duri...oussos, president and CEO of OrthoSynetics. "The,a...
... the 11 Awards Presented is the Inaugural Randy Pa...ant, EL SEGUNDO, Calif., April 15 The Pancreatic...nnounced today the 2008 Research,Grant Awards reci...six Career Development Awards and one Fellowship A...
...of colon cancer, premature aging poses worries for..., April 15 (HealthDay News) -- Astronauts may be a...ng from the high-energy radiation found in space, ...implications for the long-term space travel necess...
...ts say academics were paid to lend their names to ...s safety , , TUESDAY, April 15 (HealthDay ...ical giant Merck & Co. paid academics to put t...ller. , The company apparently also exaggerated th...
...TINUING SERIES OF PODCASTS FROM PEROT SYSTEMS ON T...HEALTHCARE LOCATION: http://perotsystems.medi... 15 Edition 18, Host: Dr. Kevin Fickenscher - Pe...Orange, California, Perot Systems continues its s...
...LN, Neb., April 15 Mark Hollis, the President of,...edit and debit card,processing in each of MacPract..."his chief concerns in offering this capability we...sident and CEO of Parallel Software stated that "w...
Other Medicine News:Health News:OrthoSynetics(TM) Expands Sales Team; Prepares to Grow 2Health News:The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding 2Health News:The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding 3Health News:The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding 4Health News: Space Radiation a Risk for Astronauts 2Health News:Key Vioxx Research Was Written by Merck, Documents Allege 2Health News:Key Vioxx Research Was Written by Merck, Documents Allege 3Health News:Key Vioxx Research Was Written by Merck, Documents Allege 4Health News:HEALTHCARE TECH AND THE WORLD: HOW INFORMATION TECHNOLOGY CAN IMPACT THE PURSUIT OF 'PERFECT CARE' 2Health News:HEALTHCARE TECH AND THE WORLD: HOW INFORMATION TECHNOLOGY CAN IMPACT THE PURSUIT OF 'PERFECT CARE' 3Health News:Parallel Software Announces Integrated Credit Card Processing for MacPractice MD, DDS, DC and 20/20 2OrthoSynetics(TM) Expands Sales Team; Prepares to GrowThe Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding Space Radiation a Risk for AstronautsKey Vioxx Research Was Written by Merck, Documents AllegeHEALTHCARE TECH AND THE WORLD: HOW INFORMATION TECHNOLOGY CAN IMPACT THE PURSUIT OF 'PERFECT CARE'Parallel Software Announces Integrated Credit Card Processing for MacPractice MD, DDS, DC and 20/20
(Date:12/2/2009)...ewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEP... U.S. District Court in Delaware against Teva Phar...ent Nos. 7,132,570 (the ",570 Patent"), 7,297,346 ...") for the Cephalon product NUVIGIL® (armodaf...eriod of marketing exclusivity for NUVIGIL that ex...
(Date:12/2/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Pharmaceutical Contract Manufacturing -...inker.com/p0164248/Pharmaceutical-Contract-Manufac... pharma industry faces numerous challenges in the ... rising cost of new product development, declining...
(Date:12/2/2009)...ewswire-USNewswire/ -- Jupiter Medical Center ha... tools available into its imaging program, the new... system delivers highly detailed images of the hum...d unique applications, including dual breast scann... with renal dysfunction. This results in shorter ...
Breaking Medicine Technology:Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 2Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 3Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5Jupiter Medical Center Announces New High-Definition MRI System 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 1Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 3Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 4Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 5Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 6Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 7Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 8Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 9Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 10Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 11Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 12Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 13Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 14Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 15State of Oklahoma Offers Invisible Bracelet Health Benefit 57571 1State of Oklahoma Offers Invisible Bracelet Health Benefit 57571 2Immucor to Announce Fiscal First Quarter Financial Results on Thursday October 1 2009 57569 1...w comparable safety for complex patients treated w...y , , NATICK, Mass., Feb. 18 Boston Scientific C...cation of results from its landmark SYNTAX(TM) tri... of Medicine. In the study, percutaneous coronary...) Paclitaxel-Eluting Coronary Stent System was com...
...TLE, Feb. 18 Cell Therapeutics, Inc.,(Nasdaq and ... efficacy data,from the phase III trial of pixantr... benefit for pixantrone when used as single agent ...essive non-Hodgkin,s lymphoma (NHL). On an,intent-...ved a complete,remission did so during the first 2...
Other Medicine Technology:New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 2New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 3New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 4New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 5Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 2Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 3Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |